The extent of “iron-addicted phenotype” is determined by the innate expression pattern of iron regulatory proteins (i.e., CD71, FtH1, and FPN) and by the relative innate intracellular iron levels, and ultimately affects the sensitivity of tumor cells to ferroptosis (Rodriguez et al., 2022). The gene discussed is SLC40A1; the disease is neoplasm.